Impact of heart failure etiology after CRT upgrade

10 May 2026 (16:30 - 17:00)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Associate Professor Annamaria Kosztin

Semmelweis University Heart and Vascular Center, Budapest (Hungary)

4 More presentations in this session

Presentation thumbnail

Impact of early initiation of sodium-glucose cotransporter 2 inhibitors on cardiac remodeling in patients with acute myocardial infarction: a meta-analysis and trial sequential analysis of controlled

Associate Professor D. D'Amario (Novara, IT)

Abstract Slides Video

Presentation thumbnail

Real-world outcomes and predictors of LV reverse remodelling after successful CTO PCI in HFrEF: insights from a multicentre registry

Assistant Professor J. Park (Busan, KR)

Abstract Slides Video

Presentation thumbnail

PCSK9 inhibition and cardiovascular outcomes by heart failure status: a pooled analysis of SPIRE-1 and SPIRE-2

Mr A. Razaghizad (Montreal, CA)

Abstract Slides Video

Presentation thumbnail

Clinical outcomes of beta-blocker therapy after myocardial infarction in patients with preserved or mildly reduced ejection fraction

Doctor B. Resende (Coimbra, PT)

Abstract Slides Video

Access the full session

Session thumbnail

Integrated and multidisciplinary care strategies to prevent remodelling in heart failure

The Event

Event poster

Heart Failure 2026

10 May 2026 16:30 CET

You may be interested in

Congress Presentation

Differential outcomes of cardiac resynchronization therapy based on heart failure etiology

Congress Presentation

BUDAPEST CRT Upgrade: Cardiac resynchronisation therapy upgrade in heart failure with right ventricular pacing - a multicentre, randomised, controlled trial

Congress Presentation

Could ischemic etiology condemn patients to 'non-response' in cardiac resynchronization therapy?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources